SCHEMBL2767534

SCHEMBL2767534

COc1ccc(N2CCN(C(=O)c3ccccc3)CC2)cc1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.81
HTR2A P28223 1/20 0.81
ALDH1A1 P00352 6/20 0.77
GAA P10253 1/20 0.77
KDM4E B2RXH2 2/20 0.71
HTT P42858 1/20 0.71
MCL1 Q07820 1/20 0.70
USP2 O75604 2/20 0.70
SMN1; SMN2 Q16637 2/20 0.70
CYP3A4 P08684 1/20 0.70
LMNA P02545 3/20 0.69
ALOX15 P16050 1/20 0.69
POLB P06746 2/20 0.68
KMT2A Q03164 2/20 0.67
TDP1 Q9NUW8 1/20 0.66
NAMPT P43490 1/20 0.65
MAPK1 P28482 2/20 0.64
CYP2C9 P11712 1/20 0.64
HIF1A Q16665 1/20 0.64
MEN1 O00255 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19479126 0.92 ALDH1A1 (0.83) DRD2HTR2AALDH1A1GAAKDM4E
SCHEMBL10144128 0.87 PARP14 (0.77) DRD2HTR2AALDH1A1GAAKDM4E
SCHEMBL27508888 0.87 ALDH1A1 (0.75) DRD2HTR2AALDH1A1GAAKDM4E
SCHEMBL16151037 0.87 MAPT (0.70) DRD2HTR2AALDH1A1HTTUSP2
SCHEMBL19561830 0.86 ALDH1A1 (0.73) DRD2HTR2AALDH1A1USP2SMN1; SMN2
SCHEMBL4418537 0.85 DRD2 (0.62) DRD2HTR2AALDH1A1GAAKDM4E
SCHEMBL2464580 0.85 ALDH1A1 (0.66) DRD2HTR2AALDH1A1GAAKDM4E
SCHEMBL13257654 0.85 MAPT (0.74) DRD2HTR2AALDH1A1KDM4EHTT
SCHEMBL8595777 0.84 POLB (0.87) DRD2HTR2AALDH1A1USP2LMNA
SCHEMBL13257660 0.84 ALDH1A1 (0.77) DRD2HTR2AALDH1A1GAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1627871-B1 CYCLIC AMINOPHENYL SULFAMATE DERIVATIVE ASKA PHARM CO LTD (JP) 2010-04-14 EP disclosed
US-7449466-B2 Cyclic aminophenyl sulfamate derivative ASKA PHARMACEUTICAL CO., LTD. (JP) 2008-11-11 US disclosed
US-20060189625-A1 Cyclic aminophenyl sulfamate derivative ASKA PHARMACEUTICAL CO., LTD. (JP) 2006-08-24 US disclosed
EP-1627871-A1 CYCLIC AMINOPHENYL SULFAMATE DERIVATIVE Teikoku Hormone Mfg. Co., Ltd. (JP) 2006-02-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060189625-A1 Cyclic aminophenyl sulfamate derivative SHBG, STS, ARSA DRD2 3225/4885HTR2A 2338/4885ALDH1A1 2953/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.